| Literature DB >> 31457864 |
Farideh Jalilehvand1, Alejandra Enriquez Garcia1, Pantea Niksirat1.
Abstract
We have combined results from several spectroscopic techniques to investigate the aerobic reactions of Rh2(AcO)4 (Entities:
Year: 2017 PMID: 31457864 PMCID: PMC6644637 DOI: 10.1021/acsomega.7b01090
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Scheme 1Structures of [RhII2(AcO)4] (1), [RhII2(AcO)2(bpy)2(CH3CN)2]2+ (2), and Its Reaction Products with Thiolates: [RhII(μ-S-C6H5S)(η1-S-C6H5S)(bpy)]2 (3′), [RhIII(μ-S,N-C6H6NS)(η1-S-C6H6NS)(bpy)]22+ (3a), and [RhIII(S,N-C6H6NS)2(bpy)]+ (3b) Reported in Refs (13−15)
Figure 1(Left) UV–vis spectroscopy of reaction progress for Rh2(AcO)4 with H2NAC (mole ratio of 1:4, C = 1.0 mM, pH of mixing = 2.8); peak positions are obtained from second derivatives. (Right) ESI-mass spectrum (+ ion mode) of the same solution measured after 48 h; see Table for peak assignments.
Assignment of the ESI-MS Peaks Shown in Figure (Right)a
| isotopic pattern | assignment | isotopic pattern | assignment | ||
|---|---|---|---|---|---|
| 186.02 | M + 1 | [H2NAC + Na+]+ | 627.88 | M + 1 | [2RhII + 4AcO– + H2NAC + Na+]+ |
| 325.05 | M + 1 | [2H2NAC – 2H+ + H+]+ | 671.08 | M + 1 | [4H2NAC – 4H+ + Na+]+ |
| 347.03 | M + 1 | [2H2NAC – 2H+ + Na+]+ | 766.91 | M + 1 | [2RhIII + 4AcO– + 2HNAC– + H+]+ |
| 459.90 | M + 1 | [2RhII + 4AcO– + NH4+]+ | 788.90 | M + 1 | [2RhIII + 4AcO– + 2HNAC– + Na+]+ |
| 464.85 | M + 1 | [2RhII + 4AcO– + Na+]+ | 810.88 | M + 1 | [2RhIII + 4AcO– + 2HNAC– – H+ +2Na+]+ |
| 505.88 | M + 1 | [2RhII + 4AcO– + CH3CN + Na+]+ |
H2NAC = C5H9NO3S; 2H2NAC – 2H+ is the oxidized form of N-acetylcysteine with an S–S bond; AcO– = CH3COO–.
Figure 2ESI-mass spectra (− ion mode) of the products (in water) obtained from the reactions of Rh2(AcO)4 with cysteine (5, top), penicillamine (6, middle), and N-acetylcysteine (7, bottom) at a mole ratio of 1:4 at pH = 7.4 (fragmentor voltage 80 V). For peak assignments, see Table .
Assignment of the Mass Ions Observed in the ESI-Mass Spectra (− Ion Mode) of Products 5–7 Shown in Figure a
| isotopic pattern | assignment | isotopic pattern | assignment | ||
|---|---|---|---|---|---|
| Rh–Cysteine Product ( | |||||
| 340.91 | M + 0.5 | [2RhIII + 4H2Cys – 8H+]2– | 511.87 | M + 0.5 | [3RhIII + 6H2Cys – 11H+]2– |
| M + 0.33 | [3RhIII + 6H2Cys – 12H+]3– | 519.87 | M + 0.5 | [3RhIII + 6H2Cys – 11H+ + O]2– | |
| 348.91 | M + 0.5 | [2RhIII + 4H2Cys – 8H+ + O]2– | 682.83 | M + 0.5 | [4RhIII + 8H2Cys – 14H+]2– |
| 356.91 | M + 0.5 | [2RhIII + 4H2Cys – 8H+ + 2O]2– | M + 1 | [2RhIII + 4H2Cys – 7H+]− | |
| 409.42 | M + 0.5 | [2RhIII + 5H2Cys – 8H+ + O]2− | 690.83 | M + 0.5 | [4RhIII + 8H2Cys – 14H+ + O]2– |
| 417.42 | M + 0.5 | [2RhIII + 5H2Cys – 8H+ + 2O]2– | 698.83 | M + 0.5 | [4RhIII + 8H2Cys – 14H+ + 2O]2– |
| 454.89 | M + 0.33 | [4RhIII + 8H2Cys – 15H+]3– | M + 1 | [2RhIII + 4H2Cys – 7H+ + O]− | |
| Rh–Penicillamine Product ( | |||||
| 339.44 | M + 0.5 | [2RhIII +3H2Pen + S2– – 6H+]2– | 794.96 | M + 0.5 | [4RhIII + 8H2Pen – 14H+]2– |
| 347.44 | M + 0.5 | [2RhIII + 3H2Pen + S2– – 6H+ + O]2– | M + 1 | [2RhIII + 4H2Pen – 7H+]− | |
| 355.44 | M + 0.5 | [2RhIII + 3H2Pen + S2– – 6H+ + 2O]2– | 810.95 | M + 0.5 | [4RhIII + 8H2Pen – 14H+ + O]2– |
| 396.98 | M + 0.5 | [2RhIII + 4H2Pen – 8H+]2– | M + 1 | [2RhIII + 4H2Pen – 7H+ + O]− | |
| 404.97 | M + 0.5 | [2RhIII + 4H2Pen – 8H+ + O]2– | 816.94 | M + 1 | [2RhIII + 4H2Pen – 8H+ + Na+]− |
| 412.97 | M + 0.5 | [2RhIII + 4H2Pen – 8H+ + 2O]2– | 826.95 | M + 1 | [2RhIII + 4H2Pen – 7H+ + 2O]− |
| Rh– | |||||
| 323.04 | M + 1 | [2H2NAC – 3H+]− | 637.91 | M + 0.5 | [3RhIII + 6H2NAC – 11H+]2– |
| 344.43 | M + 0.5 | [2RhII + 3H2NAC – 6H+]2– | M + 0.25 | [6RhIII + 12H2NAC – 22H+]4– | |
| 424.93 | M + 0.5 | [2RhIII + 4H2NAC – 8H+]2– | 648.90 | M + 0.5 | [3RhIII + 6H2NAC – 12H+ + Na+]2– |
| M + 0.33 | [3RhIII + 6H2NAC – 12H+]3– | M + 0.25 | [6RhIII + 12H2NAC – 24H+ + 2Na+]4– | ||
| 432.93 | M + 0.5 | [2RhIII + 4H2NAC – 8H+ + O]2– | 850.87 | M + 1 | [2RhIII + 4H2NAC – 7H+]− |
| 506.45 | M + 0.25 | [2RhIII + 5H2NAC – 10H+]4– | M + 0.5 | [4RhIII + 8H2NAC – 14H+]2– | |
| 512.57 | M + 0.33 | [4RhIII + 7H2NAC – 15H+]3– | M + 0.33 | [6RhIII + 12H2NAC – 21H+]3– | |
| 556.39 | M + 0.5 | [3RhIII + 5H2NAC – 11H+]2– | 861.87 | M + 0.5 | [4RhIII + 8H2NAC – 15H+ + Na+]2– |
| M + 0.25 | [6RhIII + 10H2NAC – 22H+]4– | 872.86 | M + 1 | [2RhIII + 4H2NAC – 8H+ + Na+]− | |
| 566.92 | M + 0.33 | [4RhIII + 8H2NAC – 15H+]3– | M + 0.5 | [4RhIII + 8H2NAC – 16H+ + 2Na+]2– | |
| 621.26 | M + 0.33 | [4RhIII + 9H2NAC – 15H+]3– | M + 0.33 | [6RhIII + 12H2NAC −24H+ + 3Na+]3– | |
H2Cys = C3H7NO2S; H2Pen = C5H11NO2S; H2NAC = C5H9NO3S; 2H2NAC – 2H+ is the oxidized form of N-acetylcysteine with a S–S bond.
Figure 3Sulfur K edge XANES spectra (left) and the corresponding smoothed second derivatives (right) of the solid products obtained from the reactions of Rh2(AcO)4 with cysteine (5), penicillamine (6), or N-acetylcysteine (7) at a mole ratio of 1:4 at pH = 7.4.
Figure 4k3-Weighted Rh K edge EXAFS spectra (left) and the corresponding Fourier transforms (right) of the solid products obtained from the reactions of Rh2(AcO)4 with cysteine (5), penicillamine (6), and N-acetylcysteine (7) at a mole ratio of 1:4 at pH = 7.4, compared to those of a concentrated solution of the dinuclear Rh-glutathione reaction product (8) (see Table ).
Least-Squares Curve-Fitting Results for EXAFS Spectra of the Solid Reaction Products 5–7 and a Concentrated Solution of the Rh–Glutathione Reaction Product 8a,b
| Rh–(N/O) | Rh–S | Rh···Rh | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| sample | CN | σ2 (Å2) | CN | σ2 (Å2) | CN | σ2 (Å2) | Δ | ||||
| 2.0 | 2.10 | 0.0037 | 4.1 | 2.34 | 0.0044 | 2.0 | 3.44 | 0.0142 | 0.7 | 14.7 | |
| 3.2 | 2.10 | 0.0039 | 3.2 | 2.315 | 0.0042 | 0.77 | 3.03 | 0.0078 | –0.4 | 18.5 | |
| 2 | 2.09 | 0.0032 | 4.6 | 2.32 | 0.0050 | 0.80 | 3.10 | 0.0047 | –0.2 | 17.5 | |
| 2.5 | 2.08 | 0.0034 | 4.1 | 2.33 | 0.0050 | 0.85 | 3.11 | 0.0046 | 1.2 | 17.6 | |
See Figure .
Amplitude reduction factor (S02) = 0.92 fixed;[23]f = fixed value; estimated errors: R ± 0.02 Å; σ2 ± 0.001 Å2; CN ± 10–15%.
Uncertain values for 5 and 6 (see text).
= fitting residual (%).
Figure 5Solid state 13C CPMAS NMR spectra obtained for Rh2(AcO)4 and its reaction products at a mole ratio of 1:4 with the ligands cysteine (4, pH = 3.2; 5, pH = 7.4), penicillamine (6), and N-acetylcysteine (7), and for the pure solid ligands.
Scheme 2Proposed Pathway for Aerobic Reaction of Rh2(AcO)4 with Penicillamine: (a) [RhII2(AcO)4(H2Pen)], (b) [RhIII2(AcO)4(HPen)2], (c) H2[RhIII(Pen)4], and Its Oxidized Form (d) H2[Rh2(Pen)2(Pen(SO))2], All Detected by ESI-MS at Acidic pH
The reactions occur much faster at pH = 7.4, leading to compound 6, Na2[Rh2(Pen)2(Pen(SO))2]·4.5H2O, with a structure similar to (d).
Scheme 3Proposed Structures for a Tetrameric {Na2[Rh2(Cys)4]}2 Complex in Compound 5
The lower image is its oxidized form, detected by ESI-MS, with sulfenato (S=O) groups.
Scheme 4Proposed Oligomeric Structures for the {Na2[Rh2(NAC)4]·4.5H2O} (Compound 7)